Comparison of s-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (CAPOX) as adjuvant chemotherapies in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: a randomized, controlled clinical trial

Name: Comparison of s-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (CAPOX) as adjuvant chemotherapies in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: a randomized, controlled clinical trial
Creator: Xin Liu
Published: 2023-02-13T14:56:39.601Z
Keywords: Surgery, Chemotherapy

Liu, Xin

doi:10.17632/2648w95g9x.1

Comparison of s-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (CAPOX) as adjuvant chemotherapies in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: a randomized, controlled clinical trial

Published: 13 February 2023| Version 1 | DOI: 10.17632/2648w95g9x.1

Contributor:

Xin Liu

Description

This data is for "Comparison of s-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (CAPOX) as adjuvant chemotherapies in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: a randomized, controlled clinical trial".

Comparison of s-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (CAPOX) as adjuvant chemotherapies in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: a randomized, controlled clinical trial

Description

Files

Categories

Licence